Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting João Morais, Carlos Aguiar, Euan McLeod, Ismini Chatzitheofilou, Isabel Fonseca Santos, Sónia Pereira

Clinical and economic consequences of using dabigatran or rivaroxaban in patients with non-valvular atrial fibrillation Luís Silva Miguel, Jorge Ferreira

Systematic review of cost-effectiveness analyses of novel oral anticoagulants for stroke prevention in atrial fibrillation João Ferreira, Ana Mirco